How big is the Biologics Market?

The Biologics Market size is expected to reach USD 373.5 billion in 2024 and grow at a CAGR of 10.49% to reach USD 615 billion by 2029. Read More

What is the current Biologics Market size?

In 2024, the Biologics Market size is expected to reach USD 373.5 billion. Read More

Who are the key players in Biologics Market?

Amgen, Inc., Eli Lilly and Company, GlaxoSmithKline PLC, Abbvie Inc. and F. Hoffmann- La Roche AG are the major companies operating in the Biologics Market. Read More

Which is the fastest growing region in Biologics Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Biologics Market?

In 2024, the North America accounts for the largest market share in Biologics Market. Read More

What years does this Biologics Market cover, and what was the market size in 2023?

In 2023, the Biologics Market size was estimated at USD 334.32 billion. The report covers the Biologics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Biologics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

What are the key factors driving the Biologics Market?

The Biologics Market is driven by a) Rise in the prevalence of chronic diseases b) Growing demand and higher acceptability for innovative therapies, c) Loss of patent exclusivity of the leading biologic drugs Read More

Biologics Market Share

Statistics for the 2023 & 2024 Biologics market share, created by Mordor Intelligence™ Industry Reports. Biologics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Biologics Industry

The biologics industry is moderately competitive and consists of several major players. Biologic companies are implementing specific strategic initiatives such as mergers, new product launches, acquisitions, and partnerships that help them strengthen their market positions. These companies have made substantial capital investments in the research and development of biologics, as the cost of biologics is relatively high. Some top biologics companies include Amgen, Inc., Eli Lilly and Company, GlaxoSmithKline PLC, Abbvie Inc., and F. Hoffmann-La Roche AG.